Related Experiment Video
Updated: Feb 10, 2026

Isolation and Culture of Adult Mouse Cardiomyocytes for Cell Signaling and in vitro Cardiac Hypertrophy
Published on: May 21, 2014
GDF11 Modulates Ca2+-Dependent Smad2/3 Signaling to Prevent Cardiomyocyte Hypertrophy
Javier Duran1, Mayarling Francisca Troncoso2, Daniel Lagos3
1Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, Santiago 8389100, Chile. javiadg@ug.uchile.cl.
Abstract:
Growth differentiation factor 11 (GDF11), a member of the transforming growth factor-β family, has been shown to act as a negative regulator in cardiac hypertrophy. Ca2+ signaling modulates cardiomyocyte growth; however, the role of Ca2+-dependent mechanisms in mediating the effects of GDF11 remains elusive. Here, we found that GDF11 induced intracellular Ca2+ increases in neonatal rat cardiomyocytes and that this response was blocked by chelating the intracellular Ca2+ with BAPTA-AM or by pretreatment with inhibitors of the inositol 1,4,5-trisphosphate (IP₃) pathway. Moreover, GDF11 increased the phosphorylation levels and luciferase activity of Smad2/3 in a concentration-dependent manner, and the inhibition of IP₃-dependent Ca2+ release abolished GDF11-induced Smad2/3 activity. To assess whether GDF11 exerted antihypertrophic effects by modulating Ca2+ signaling, cardiomyocytes were exposed to hypertrophic agents (100 nM testosterone or 50 μM phenylephrine) for 24 h. Both treatments increased cardiomyocyte size and [³H]-leucine incorporation, and these responses were significantly blunted by pretreatment with GDF11 over 24 h. Moreover, downregulation of Smad2 and Smad3 with siRNA was accompanied by inhibition of the antihypertrophic effects of GDF11. These results suggest that GDF11 modulates Ca2+ signaling and the Smad2/3 pathway to prevent cardiomyocyte hypertrophy.
Insights
Growth differentiation factor 11 (GDF11) prevents cardiac hypertrophy by increasing intracellular calcium and activating Smad2/3 signaling. This mechanism involves the inositol 1,4,5-trisphosphate pathway, suggesting GDF11 as a therapeutic target.
Area of Science:
- Cardiovascular Biology
- Cell Signaling
- Molecular Medicine
Background:
- Growth differentiation factor 11 (GDF11), a TGF-β family member, inhibits cardiac hypertrophy.
- Calcium (Ca2+) signaling regulates cardiomyocyte growth, but its role in GDF11's effects is unclear.
Purpose of the Study:
- To elucidate the role of Ca2+-dependent mechanisms in GDF11's regulation of cardiac hypertrophy.
- To investigate the interplay between GDF11, Ca2+ signaling, and the Smad2/3 pathway in cardiomyocytes.
Main Methods:
- Neonatal rat cardiomyocytes were treated with GDF11 and assessed for intracellular Ca2+ levels using BAPTA-AM and inositol 1,4,5-trisphosphate (IP3) pathway inhibitors.
- Smad2/3 phosphorylation and activity were measured following GDF11 treatment.
- Cardiomyocytes were exposed to hypertrophic agents (testosterone or phenylephrine) with or without GDF11 pretreatment.
- Smad2 and Smad3 were downregulated using siRNA to assess their role in GDF11's antihypertrophic effects.
Main Results:
- GDF11 induced intracellular Ca2+ increases, mediated by the IP3 pathway.
- GDF11 enhanced Smad2/3 phosphorylation and activity, which was dependent on IP3-mediated Ca2+ release.
- GDF11 pretreatment significantly blunted testosterone- or phenylephrine-induced cardiomyocyte hypertrophy (size and [3H]-leucine incorporation).
- siRNA-mediated downregulation of Smad2/3 abolished the antihypertrophic effects of GDF11.
Conclusions:
- GDF11 prevents cardiomyocyte hypertrophy by modulating intracellular Ca2+ signaling through the IP3 pathway.
- The Smad2/3 pathway is essential for mediating GDF11's antihypertrophic effects.
- GDF11's action on Ca2+ signaling and Smad2/3 activation represents a potential therapeutic strategy for cardiac hypertrophy.
Related Concept Videos
Contact-dependent Signaling
Gap Junctions
In animal cells, gap junctions are formed...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Cancer Prevention
Some...
Frequency-dependent Selection
What is Cell Signaling?

